This is a preview of subscription content, log in via an institution to check access.
Références
Shivananda S., Lennard-Jones J., Logan R. et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and South? Results of the European collaborative study on inflammatory bowel disease.Gut 1996;39: 690–7.
Eaden J.A., Mayberry J.F. Colorectal cancer complicating ulcerative colitis: a review.Am J Gastroenterol 2000;95: 2710–9.
Eaden J.A., Abrams K., Mayberry J.F. The true risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 1999; 44(suppl 1): T163 (abstract).
Provenzale D. Kowdley K.V., Arora S., et al. Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis.Gastroenterology 1995;109: 1188–96.
Bansal P., Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease.Am J Gastroenterol 1996;91: 44–8.
Bernstein C.N., Blanchard J.F., Kliewer E., Wadja A. Cancer risk in patients with inflammatory bowel disease.Cancer 2001;91: 854–62.
Friedman S., Rubin P.H., Bodian C., Harpaz N., Present D. Screening and surveillance colonoscopy in chronic Crohn’s colitis.Gastroenterology 2001;120: 820–6.
Farrell R.J., Ang Y., Kileen P., O’Briain D.S.O., Kelleher D., Keeling P.W. et al. Increased incidence of non-Hodgkin’s lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.Gut 2000;47: 514–9.
Connell W.R., Talbot I.C., Harpaz N., et al. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis.Gut 1994;35: 1419–23.
Odze R.D. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological and molecular review.Am J Gastroenterol 1999;94: 1746–50.
Connell W.R., Lennard-Jones J.E., Williams C.B., et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.Gastroenterology 1994;107: 934–44.
Choi P.M., Nugent F.W. Schoetz D.J., et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis.Gastroenterology 1993;105: 418–24.
Engelsgjerd M., Farraye F.A., Odze R.D. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis.Gastroenterology 1999;117: 1288–94.
Delco F., Sonnenberg A. A decision analysis of surveillance for colorectal cancer in ulcerative colitis.Gut 2000;46: 500–6.
Provenzale D., Wong J., Onken J.E., Lipscomb J. Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis.Am J Gastroenterol 1998;93: 872–800.
About this article
Cite this article
Barthet, M., Gay, G., Sautereau, D. et al. Surveillance endoscopique des maladies inflammatoires chroniques de l’intestin. Acta Endosc 34 (Suppl 1), 441–443 (2004). https://doi.org/10.1007/BF03006393
Issue Date:
DOI: https://doi.org/10.1007/BF03006393